Funding the Quest for Platform Technologies targeting cures rather than masking symptoms.
Fostering life sciences innovation by applying a rigorous, data-driven, survival-of-the-fittest discipline to capital allocation.
Areas of Focus
Founded in 2025 by physicians, the Owena Fund invests in disruptive biotechnologies and platform sciences that target the root causes of disease rather than just managing symptoms. The fund focuses on high-impact deals under $25 million, specializing in restructuring undervalued public companies or supporting visionary leadership teams with proven, IND-ready science.
Biotechnology
Diagnostics
Medical Devices
Focused on public biotech companies with “platform” technologies that target the root causes of disease across multiple indications in the IND or IDE stage. Looking for value driven or restructuring opportunities with failed pipelines.